WeSearch

STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion

Allison DeAngelis· ·1 min read · 0 reactions · 0 comments · 15 views
STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion

Retro Biosciences, the longevity startup backed by OpenAI CEO Sam Altman, has raised more money at a $1.8 billion valuation, it announced Friday.

Original article
STAT News · Allison DeAngelis
Read full at STAT News →
Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from STAT News

STAT+: Legend Biotech emerged as a rare market winner
STAT News·8
STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA
STAT News·17
STAT+: China competition, ‘destruction’ at FDA gives agency chance to restructure, Rick Pazdur says
STAT News·14
STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbook
STAT News·18
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
STAT News·17
STAT+: Allogene CEO David Chang stepping down
STAT News·21